SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: Mark Catalano who wrote (8542)3/13/1998 2:38:00 AM
From: milton  Respond to of 14328
 
Mark Catalano:
It's always been a mystery to me. I believe we have only had individual investors buying. These stocks under $5 cannot be recommended by the brokerage houses. Funds won't invest in these under $5 shares. Triby has been in a fantastic growth phase only since 12-96. Once the market recognizes it and the price pushes into the $5 range I believe we will see a lot of larger buyers. Other issues affecting the price is the weak pr effort of triby to trumpet its value. See this article for reassurance that the biotechs in general have all suffered from underexposure but the market is now starting to take note: Message 3690992